IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia

Cancer Research
Yoko OgawaraIssay Kitabayashi

Abstract

IDH1 and IDH2 mutations occur frequently in acute myeloid leukemia (AML) and other cancers. The mutant isocitrate dehydrogenase (IDH) enzymes convert α-ketoglutarate (α-KG) to the oncometabolite 2-hydroxyglutarate (2-HG), which dysregulates a set of α-KG-dependent dioxygenases. To determine whether mutant IDH enzymes are valid targets for cancer therapy, we created a mouse model of AML in which mice were transplanted with nucleophosmin1 (NPM)(+/-) hematopoietic stem/progenitor cells cotransduced with four mutant genes (NPMc, IDH2/R140Q, DNMT3A/R882H, and FLT3/ITD), which often occur simultaneously in human AML patients. Conditional deletion of IDH2/R140Q blocked 2-HG production and maintenance of leukemia stem cells, resulting in survival of the AML mice. IDH2/R140Q was necessary for the engraftment or survival of NPMc(+) cells in vivo. Gene expression analysis indicated that NPMc increased expression of Hoxa9. IDH2/R140Q also increased the level of Meis1 and activated the hypoxia pathway in AML cells. IDH2/R140Q decreased the 5hmC modification and expression of some differentiation-inducing genes (Ebf1 and Spib). Taken together, our results indicated that IDH2 mutation is critical for the development and maintenance of AML ste...Continue Reading

References

Sep 14, 2002·Science·Natalia B IvanovaIhor R Lemischka
Jan 22, 2005·The New England Journal of Medicine·Brunangelo FaliniUNKNOWN GIMEMA Acute Leukemia Working Party
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Oct 8, 2005·Stem Cells·Taina JaatinenJukka Partanen
Jun 14, 2006·Journal of Leukocyte Biology·Anna L BrownRichard J D'Andrea
Jul 25, 2006·Nature·Andrei V KrivtsovScott A Armstrong
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Mar 2, 2011·The American Journal of Pathology·Tatsuhiro ShibataNaoya Yamazaki
Apr 5, 2011·EMBO Reports·Rasheduzzaman ChowdhuryAkane Kawamura
Aug 18, 2012·Nature Reviews. Cancer·Alan H ShihRoss L Levine
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
Sep 26, 2013·Genes & Development·Chao LuCraig B Thompson
Jan 21, 2014·Cell Stem Cell·Lev M KatsPier Paolo Pandolfi
Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·M Ryan Corces-ZimmermanRavindra Majeti
Jul 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ageliki TsagaratouAnjana Rao
Aug 12, 2014·Science·David Lara-AstiasoIdo Amit

❮ Previous
Next ❯

Citations

May 18, 2016·Experimental Hematology·Ugo TestaElvira Pelosi
Mar 16, 2018·Future Oncology·Guillermo Montalban-Bravo, Courtney D DiNardo
Jan 19, 2018·International Journal of Molecular Sciences·Silje JohansenØystein Bruserud
Jun 20, 2019·Cancers·Mélanie LambertMarie-Hélène David-Cordonnier
Jul 8, 2020·Blood Advances·Molly C KingsleyKathrin M Bernt
Jan 1, 2015·Experimental Hematology & Oncology·Hanna Grauers WiktorinAnna Martner
Aug 21, 2019·Genes·Si-Liang ChenYang Liang
Jan 29, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Owen ClarkIngo K Mellinghoff
Jun 17, 2021·Leukemia·Ghayas C IssaMichael Andreeff
Jul 17, 2021·International Journal of Laboratory Hematology·Jingtao LuHongying Chao
Oct 8, 2021·Communications Biology·Josephine T DaubPatrick Kemmeren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.